Showing results (191-200 of 654) with videos related to

Sort By:
Pageof 66
Journal of Cellular Physiology|January 15, 2019
Tumor-derived exosomes: Potential biomarkers and therapeutic target in the treatment of colorectal cancerSousan Mousavi, Roya Moallem, Seyed Mahdi Hassanian, et al.
Journal of Cellular Physiology|May 10, 2018
Anti-tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancerSeyed Alireza Javadinia, Arezoo Gholami, Mona Joudi Mashhad, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 9, 2024
The association of dietary indices for hyperinsulinemia and insulin resistance with the risk of metabolic syndrome: a population-based cross-sectional studyNajmeh Seifi, Hossein Bahari, Elaheh Foroumandi, et al.
Journal of Cellular Biochemistry|May 18, 2017
The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and ProgressAfsane Bahrami, Majid Khazaei, Soodabeh Shahidsales, et al.
Journal of Cellular Biochemistry|November 29, 2018
Gold nanoparticle and polyethylene glycol in neural regeneration in the treatment of neurodegenerative diseasesTayebe Aghaie, Mir Hadi Jazayeri, Mostafa Manian, et al.
Journal of Cellular Physiology|December 9, 2017
Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancerMohammad Jalili-Nik, Arash Soltani, Soussan Moussavi, et al.
Current Pharmaceutical Design|January 19, 2023
Remodeling of the Gut Microbiota in Colorectal Cancer and its Association with ObesityNima Zafari, Mahla Velayati, Shima Mehrabadi, et al.
Iranian Journal of Public Health|July 22, 2022
The Effects of Vitamin D Fortified Products on Bone Biomarkers: A Systematic Review and Meta-AnalysisMaryam Emadzadeh, Atieh Mehdizadeh, Payam Sharifan, et al.
Current Cancer Drug Targets|June 24, 2022
Targeting the Transforming Growth Factor-beta Signaling Pathway in the Treatment of Gynecologic CancerSadaf Ghanaatgar-Kasbi, Farzaneh Pouya, Negar Khoshghamat, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4Reza Nedaeinia, Mohammadreza Sharifi, Amir Avan, et al.
Pageof 66